Microencapsulated Engineered Lactococcus lactis Cells for Heterologous Protein Delivery: Preparation and In Vitro Analysis

Abstract

This article demonstrates the potential of encapsulated, engineered Lactococcus lactis as a vehicle for the oral delivery of therapeutic proteins. Using alginate-poly-l-lysine-alginate membrane-encapsulated L. lactis engineered to secrete the reporter protein Staphylococcal aureus nuclease, we show comparable viability and protein secretion between free and immobilized cells. After 12 h, microcapsules with a cell density of 4.8 × 10⁵ colony forming unit (CFU) ml⁻¹ grew to 2.2 × 10⁸ CFU ml⁻¹ and released 0.24 arbitrary unit (AU) ml⁻¹ of nuclease, producing similar results as free cells, which grew from 3.4 × 10⁵ to 1.9 × 10⁸ CFU ml⁻¹ and secreted 0.21 AU ml⁻¹ of nuclease. Moreover, encapsulated cells at a density of 4.4 × 10⁷ CFU ml⁻¹ grew to 2.2 × 10¹⁰ CFU ml⁻¹ in 12 h and secreted 15.3 AU ml⁻¹ of nuclease although 3.1 × 10⁷ CFU ml⁻¹ of free cells reached only 2.3 × 10⁹ CFU ml⁻¹ and released 5.6 AU ml⁻¹ of nuclease. We also show the sustained stability of the microcapsules during storage at 4°C over 8 weeks.